Diovan takes on Norvasc
Sales of Novartis Korea's antihypertensive medicine are estimated at 78 billion won last year, making it one of the top-selling drugs in the country.
Diovan, an angiotensin II receptor blocker (ARB), i...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
